Farallon Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $4.01 Million - $5.34 Million	116,000 New	116,000 $4.73 Million
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $6.12 Million - $20.6 Million	-325,000 Reduced 59.09%	225,000 $12.2 Million
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $7.48 Million - $9.45 Million	-290,000 Reduced 34.52%	550,000 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $3.8 Million - $5.85 Million	190,000 Added 29.23%	840,000 $23 Million
Q1 2018 May 15, 2018	SELL	$19.43 - $34.95 $9.52 Million - $17.1 Million	-490,000 Reduced 42.98%	650,000 $13.7 Million
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $19.8 Million - $35.5 Million	1,140,000	1,140,000 $21.9 Million

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.